Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...
Injectable, extended-release buprenorphine was deemed safe for patients experiencing minimal to mild opioid withdrawal (COWS scores 4-7), making the drug a viable and safe treatment option, according ...
With historically high overdose death rates in U.S., multi-site NIH study reinforces importance of continued, uninterrupted access to addiction medication Results from a multi-site clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results